MOH
- Status: likely_approved
🇮🇱 Sunpg 1622 in Israel
Sunpg 1622 (TILDRAKIZUMAB) regulatory status in Israel.
Marketing authorisations
MOH
- Status: likely_approved
Sunpg 1622 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Israel
Frequently asked questions
Is Sunpg 1622 approved in Israel?
Yes. MOH has authorised it; MOH has authorised it.
Who is the marketing authorisation holder for Sunpg 1622 in Israel?
Sun Pharma Global is the originator. The local marketing authorisation holder may differ — check the official source linked above.